Mackanin happy with first impression of Goeddel

Rule 5 pick hits two-run double as part of Phillies' 12-run outburst vs. Braves

Mackanin happy with first impression of Goeddel

CLEARWATER, Fla. -- Manager Pete Mackanin heard Tyler Goeddel was pretty good even before the Phillies took the outfielder with the first pick in the Rule 5 draft last December at the Winter Meetings.

He heard good things about the two hits Goeddel got against the Yankees in a split squad game in Tampa on Thursday while he was managing the squad that stayed behind to play the Astros.

He finally got to see it for himself on Friday when the 23-year-old outfielder whacked a two-run double in a 12-11 win over the Braves at Bright House Field.

Spring: Tickets | Ballpark | 40-man roster | NRIs

"At the Winter Meetings, his name came up quite a bit, and not just from our people in our room. Friends of mine on different teams mentioned how much they liked him. Scouts that I knew told me he was a pretty good-looking player," Mackanin said. "And I had heard he looked really good on [Thursday.] This was my first chance to see him, and I like him a lot."

In a precautionary move, Goeddel left the game after being hit on the helmet by an off-speed pitch in the sixth.

"I feel good. They checked me out and everything's fine," he said.

Goeddel's two-run double

Goeddel, who was left unprotected by Tampa Bay after batting .279 with a .783 OPS for Double-A Montgomery last season, will get a long look this spring. But he also wants to make a good first impression.

"At the same time, I'm trying not to put too much pressure on myself. I want to show them what I can do. So I'm trying to come out every day and do something to help the team, whether it's in the batter's box or out on defense. I'm just trying to compete."

And, yes, he was aware that this was the first time he was playing in front of Mackanin.

"A little bit," he said. "I'm sure he reads the reports. But obviously I want to play well in front of Pete and the rest of the staff. It was nice to get a hit in front of him for sure."

Goeddel also has an interesting back story. His father, David, is a legend in the biotechnology industry. While at Genentech, he successfully used genetic engineering to make bacteria create synthetic human insulin, human growth hormone for use in therapeutic medicine. Later he co-founded a company, Tularik, in 1991, that sold for $1.3 billion in 2004.

"He's a pretty smart guy," Goeddel said. "Human growth hormone is a hormone [that occurs naturally] in your body. He was able to clone it so people who need more can take it. It's funny with all the baseball HGH stuff going on. It's definitely ironic, being in professional baseball with all that stuff going on."

His brother also played baseball at UCLA. As a result, their father has taken more interest in the sport.

"Ever since we got to high school he's been part of the baseball craze. Reads everything on it. Tries to learn as much about the game as he can so he can help us," Goeddel said. "At this point he knows as much about baseball as any dad I know. He's been a great help for me growing up with mental stuff, physical stuff. He studies swings. He helps me with everything. It's great."

Worth Noting

• Rightfielder Aaron Altherr had to leave the game in the second inning when he jammed his left wrist while trying to make a diving catch of a line drive hit by Braves centerfielder Ender Inciarte leading off the game.

"I can't say it looked real bad, but we'll wait and see," Mackanin said.

• First baseman Ryan Howard left the game after two at bats. He was feeling the effects of the flu bug that's been sweeping through the clubhouse this spring.

• Fans have until 5 p.m. ET on Monday to vote for which player, coach or manager will be added to the Phillies Wall of Fame. The top five choices will form the official ballot for the Wall of Fame Selection Committee. Last year, Pat Burrell became the 36th alumni member to be honored. Click here to participate.

Paul Hagen is a reporter for MLB.com. This story was not subject to the approval of Major League Baseball or its clubs.